A specific biomarker, a protein released by dying tumor cells, has been identified as an effective tool in an animal model to gauge the response to a novel gene therapy treatment for glioblastoma mulitforme. The finding, reported in the July 1 issue of Clinical Cancer Research, paves the way for a Phase 1 clinical trial expected to begin in late 2009.
Full article >>
Wednesday, July 1, 2009
Study identifies biomarker that safely monitors tumor response to new brain cancer treatment
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment